We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

82 hedge funds and large institutions have $75.5M invested in Avadel Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.87M | Put options by funds: $2.41M

15% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 20

1% more funds holding

Funds holding: 81 → 82 (+1)

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.59% less ownership

Funds ownership: 60.74% → 57.15% (-3.6%)

67% less capital invested

Capital invested by funds: $230M → $75.5M (-$155M)

Holders
82
Holders Change
+1
Holders Change %
+1.23%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
23
Reduced
20
Closed
15
Calls
$2.87M
Puts
$2.41M
Net Calls
+$464K
Net Calls Change
-$2.46M

Top Buyers

Rank Fund Capital Flow
1
GJL
Gendell Jeffrey L
+$5.84M
2
PVI
Pura Vida Investments
New York
+$3.24M
3
BIP
Brandes Investment Partners
California
+$2.64M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.92M
5
MWM
Modera Wealth Management
New Jersey
+$1.74M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$11.4M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$9.63M
3
FLSM
Frazier Life Sciences Management
California
-$6.5M
4
ACP
Acuta Capital Partners
California
-$3.96M
5
WP
Woodline Partners
California
-$2.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$181K -$669K -162,951 -69%
JF
27
Jump Financial
Illinois
$137K +$103K +25,100 +80%
VFA
28
Valeo Financial Advisors
Indiana
$110K +$185K +45,000 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$98K – – –
RJA
30
Raymond James & Associates
Florida
$83K +$140K +34,141 New
Jane Street
31
Jane Street
New York
$81K +$19.8K +4,816 +17%
MML Investors Services
32
MML Investors Services
Massachusetts
$81K +$20.9K +5,100 +18%
LPL Financial
33
LPL Financial
California
$75K +$36.5K +8,900 +41%
KAS
34
Kestra Advisory Services
Texas
$74K -$66.3K -16,150 -35%
IAM
35
Iridian Asset Management
Connecticut
$73K +$123K +30,000 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$72K +$121K +29,500 New
BlackRock
37
BlackRock
New York
$70K -$32.6K -7,936 -22%
ACM
38
Aquatic Capital Management
Illinois
$65K +$107K +26,000 +4,333%
JP Morgan Chase
39
JP Morgan Chase
New York
$60K -$19.5K -4,761 -16%
Goldman Sachs
40
Goldman Sachs
New York
$51K -$99.1K -24,148 -54%
CHA
41
Carmichael Hill & Associates
Maryland
$51K +$49.3K +12,000 +133%
IBT
42
International Biotechnology Trust
United Kingdom
$50K -$205K -49,878 -100%
LP
43
LMR Partners
United Kingdom
$50K – – –
CLOS
44
Compagnie Lombard Odier SCmA
Switzerland
$47K – – –
Creative Planning
45
Creative Planning
Kansas
$39K +$8.55K +2,083 +15%
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$38K -$1.83K -447 -3%
BRWA
47
B. Riley Wealth Advisors
Florida
$37K – – –
AAS
48
Avantax Advisory Services
Texas
$33K -$2.05K -500 -4%
BSW
49
Buckingham Strategic Wealth
Missouri
$33K – – –
Envestnet Asset Management
50
Envestnet Asset Management
Illinois
$33K +$829 +202 +2%
1
2
3 4

AVDL Hedge Fund Activity: Q2 2022 in Review

82 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2022, worth a combined $75.5M — down 67% from $230M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AVDL positions and 15 closed out — a net gain of 1 holder — while 23 added to existing stakes and 20 trimmed.

The largest buyer was Gendell Jeffrey L, adding an estimated $5.84M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $11.4M sold.

  • 82 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2022, up from 81 in Q1 2022.
  • Funds reported $75.5M of Avadel Pharmaceuticals stock for Q2 2022, down 67% quarter-over-quarter.
  • 16 funds opened new Avadel Pharmaceuticals positions in Q2 2022 and 15 closed out, a net change of +1 holder.
  • The largest Avadel Pharmaceuticals buyer in Q2 2022 was Gendell Jeffrey L, an estimated $5.84M added.
  • The largest Avadel Pharmaceuticals seller in Q2 2022 was Avoro Capital Advisors, an estimated $11.4M sold.

Based on aggregated 13F filings for Q2 2022.